Literature DB >> 27585702

Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.

A Traboulsee1, D Li2.   

Abstract

Entities:  

Year:  2016        PMID： 27585702     DOI： 10.3174/ajnr.A4943

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  4 in total

1.  CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.

Authors:  Scott D Newsome; Philip J Aliotta; Jacquelyn Bainbridge; Susan E Bennett; Gary Cutter; Kaylan Fenton; Fred Lublin; Dorothy Northrop; David Rintell; Bryan D Walker; Megan Weigel; Kathleen Zackowski; David E Jones
Journal:  Int J MS Care       Date:  2016 Nov-Dec

2.  An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies.

Authors:  Lori Saslow; David K B Li; June Halper; Brenda Banwell; Frederik Barkhof; Laura Barlow; Kathleen Costello; Peter Damiri; Jeffrey Dunn; Shivraman Giri; Micki Maes; Sarah A Morrow; Scott D Newsome; Jiwon Oh; Friedemann Paul; Patrick Quarterman; Daniel S Reich; Jason R Shewchuk; Russell Takeshi Shinohara; Wim Van Hecke; Kim van de Ven; Mitchell T Wallin; Jerry S Wolinsky; Anthony Traboulsee
Journal:  Int J MS Care       Date:  2020-10-27

3.  Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.

Authors:  Robert Zivadinov; Niels Bergsland; Jesper Hagemeier; Deepa P Ramasamy; Michael G Dwyer; Ferdinand Schweser; Channa Kolb; Bianca Weinstock-Guttman; David Hojnacki
Journal:  Neurology       Date:  2019-07-08       Impact factor: 11.800

4.  Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI.

Authors:  Kianush Karimian-Jazi; Brigitte Wildemann; Ricarda Diem; Daniel Schwarz; Thomas Hielscher; Wolfgang Wick; Martin Bendszus; Michael O Breckwoldt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.